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Abstract 8 
Over the last decade, cross-linking/mass spectrometry (CLMS) has developed 9 
into a robust and flexible tool that provides medium-resolution structural 10 
information on previously intractable protein complexes and and their 11 
interactions. CLMS data describes the proximity of amino acid residues and 12 
therefore information on the fold of proteins, and the topology of their complexes. 13 
Here, we describe notable successes of this technique and common pipelines. 14 
Novel CLMS applications such as in-cell cross-linking, probing conformational 15 
changes and tertiary structure determination are beginning to make large 16 
contributions to molecular biology and the emerging fields of structural systems 17 
biology and interactomics.  18 
 19 
1. Introduction 20 
Cross-Linking/Mass Spectrometry (CLMS, also abbreviated as CL-MS, XL-MS, 21 
CX-MS, or CXMS) has developed in recent years into a robust technology that is 22 
accessible to many biochemical laboratories. It is now a standard complementary 23 
tool to traditional structural techniques1 and has benefited from intense 24 
methodological development. Pioneering laboratories now focus on expanding 25 
CLMS pipelines to generate even greater amounts of information on protein 26 
structure, protein complex topology, quantitation of conformational states and 27 
analysing protein-protein interactions (PPIs) on a system-wide scale. 28 
The cross-linking reaction adds new covalent bonds between proximal 29 
residues. Commonly, this is done with soluble cross-linkers that target surface 30 
residues (Table 1). Alternatively, photoactivatable amino acids such as photo-31 
methionine and photo-leucine2 can be globally incorporated during translation, 32 
allowing the protein interior and hydrophobic patches to be probed. Distance 33 
restraints are generated by identifying the cross-linked residues and considering 34 
the length of the most extended conformation of the cross-linking reagent. These 35 
data are then used, often in conjunction with other available structural 36 
information, for modelling the conformation of proteins and the topology of their 37 
complexes.  38 
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The experimental steps in CLMS typically involve the reaction, digestion of 39 
cross-linked proteins, enrichment of the cross-linked peptides and tandem mass 40 
spectrometry-based data acquisition followed by peptide identification by 41 
database searching (Fig. 1). There are many different approaches to each of 42 
these steps and therefore many potential ways to combine them into a pipeline3. 43 
After protein digestion, normally by trypsin, cross-linked peptides are sub-44 
stoichiometric compared to their non-cross-linked linear counterparts as not 45 
every protein or peptide is cross-linked in the same way. Detecting cross-linked 46 
peptides within these mixtures has been the longstanding bottleneck of the 47 
CLMS pipeline.  48 
Improvements in cross-linking reagents, mass spectrometers and 49 
database searching algorithms have resulted in the successful application of 50 
CLMS to systems with increasing complexity4–6 and have vastly improved the 51 
sensitivity of cross-link detection and/or identification7. Major advantages, 52 
compared with other structural techniques, are that the cross-linking reaction 53 
occurs in solution, it tolerates a large variety of buffer conditions, deals with 54 
sample heterogeneity and requires relatively small sample quantities. CLMS 55 
played a significant role in some of the most ambitious recent integrated 56 
structural biology studies, including the mitochondrial ribosome8, the mediator-57 
RNA polymerase II complex9 and the mammoth task of piecing together the 58 
membrane-bound nuclear pore complex10–12.  59 
Proteins and protein complexes are not static entities and CLMS captures the 60 
ensemble of their conformations in solution, providing information on dynamics 61 
and flexible regions. Quantitative CLMS (QCLMS) developments now allow for 62 
direct comparison of cross-links derived from a complex in different states, i.e. in 63 
the presence and absence of an effector. Differences in cross-link patterns could 64 
be due to conformational differences between the two samples. This contrasts 65 
with most other structural techniques, which normally require conformational 66 
homogeneity of the sample. CLMS also has the unique potential to contribute to 67 
the field of 'structural systems biology' by not only providing high-throughput 68 
mapping of cellular PPIs in vivo or in vitro, but also adding the missing 69 
information on protein conformations and interaction topologies to cellular 70 
interaction networks.  71 
 72 
 73 
 74 
2. CLMS applications 75 
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CLMS applied to protein assemblies 76 
The most established application of CLMS is to investigate the topology of 77 
enriched or purified protein complexes (Fig. 2a). Unlike for other structural 78 
techniques, the sample does not need to be purified, although significant 79 
enrichment of the protein complex will improve cross-link detection, and the 80 
quantities required are relatively small (10’s-100’s µg). The combination of CLMS 81 
with other structural and modelling techniques, often termed 'integrative structural 82 
biology', has been used to determine the subunit/domain organisation of 83 
complexes and assign ambiguous densities in EM maps to specific subunits13–15. 84 
It helped identify that previous structural work on the CCT chaperonin rings had 85 
placed homologous subunits in the wrong order16,17. The cross-linking reaction 86 
occurs in solution in near-native conditions and so is an ideal complementary 87 
technique to address possible artifacts of other experimental approaches such as 88 
crystal contacts perturbing protein structure. 89 
Particularly fruitful recent applications of CLMS in combination with high-90 
resolution electron microscopy have provided important structural information on 91 
the positions and orientations of subunits for challenging large protein 92 
assemblies that had previously eluded structural determination. These structures 93 
include: the 26S proteasome holocomplex structure18, the 40S ribosome-eIF1-94 
eIF3 complex19, the chromatin-remodelling complex SWR120, the INO80 95 
chromatin remodeller21, the RNA polymerase II-TFIIF complex13, RNA 96 
polymerase II coupled with the pre-mRNA capping complex22, RNA polymerase 97 
II-mediator core initiation complex9, the mitochondrial ribosome8, the yeast 98 
spliceosome23 and the nuclear pore complex11,12. 99 
CLMS paired with integrative protein structural modelling has spurred the 100 
development of specialised restraint-driven pipelines where the cross-links put 101 
limitations on potential subunit orientations, restricting the energy landscape to 102 
drive sampling in a way that will lead to accurate models24,25. Further valuable 103 
topological information such as stoichiometries and surface-accessible regions 104 
can be integrated from other MS-based technologies such as ion mobility MS, 105 
native MS26 and hydrogen−deuterium exchange MS27. Lower-resolution 106 
structural models of complexes that are not amenable to standard structural 107 
techniques can be built by combining biochemical and genetic evidence with 108 
CLMS and available atomic-level information, as work on the SAGA transcription 109 
coactivator complex28 and the SEA complex29 demonstrate.  110 
CLMS cannot normally discriminate between intra-subunit and inter-111 
subunit cross-links in homomultimeric complexes except for the rare case where 112 
a cross-link is identified between two peptides that overlap in sequence and 113 
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therefore cannot be from the same protein molecule30. An elegant solution to this 114 
is to mix stable isotope-labelled subunits e.g. 15N-labelled protein with unlabelled 115 
14N protein31. Cross-links between subunits are differentiated as linking a 15N 116 
labelled peptide to a 14N peptide that has been used to analyse the oligomeric 117 
state of guanylyl cyclase-activating protein 232 and p5333. 118 
CLMS can also be used to confirm that complex topologies derived from in 119 
vitro experiments correspond to those found in situ. In a study on the 120 
SMC2/SMC4 subcomplex34, the purified complex was first analysed by CLMS in 121 
vitro. To validate that the identified in vitro topology occurs in the cell, the 122 
detected cross-links were used to direct a targeted mass spectrometry approach 123 
in order to find the same cross-links in in situ cross-linked chromatin.  124 
The approaches described above rely on a combination of lower density 125 
cross-links with higher resolution information about individual subunits. However, 126 
such information is not always available for all subunits within a complex. 127 
Furthermore, the analysed system may undergo conformational changes or 128 
display a dynamic behaviour that cannot be deduced from the structures of the 129 
individual subunits. 130 
CLMS for tertiary protein structure determination 131 
A truly non-specific cross-linker could provide distance restraints between 132 
surface residues of any type. The potential combinations of cross-linked residues 133 
obtained with such a cross-linker means that the data would be challenging to 134 
analyse. A compromise is to use heterobifunctional reagents such as 135 
sulfosuccinimidyl 4,4-azipentanoate (sulfo-SDA). This cross-linker combines a 136 
sulfo-NHS ester and a promiscuous UV photoactivatable diazirine group7. One 137 
arm of this cross-linker is first anchored on a lysine, serine, threonine or tyrosine 138 
and the other is free to link any residue after photoactivation, making data 139 
acquisition and analysis simpler than for a truly random cross-linker. Data from 140 
this type of cross-linker has been termed high-density cross-linking (HD-141 
CLMS)35,36. Nevertheless, the increased sample complexity and the increased 142 
search space have so far limited the application of this approach to single 143 
proteins. 144 
High-density information from CLMS can be leveraged to facilitate 145 
generation of structural models de novo without any prior knowledge of the 146 
protein structure (Fig. 2b). HD-CLMS derived distance restraints are combined 147 
with computational approaches that predict protein folds by restraining the 148 
proximity of structural domains, loops and residues. Small numbers of cross-links 149 
have previously been used to validate predictions made through computational 150 
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approaches37,38, and have proven to be largely complementary to evolutionary 151 
conserved contacts39. In the first study to show that it is possible to collect the 152 
numbers of restraints with sulfo-SDA required to make sensible tertiary structure 153 
predictions, we probed the 66 kDa human serum albumin. This study reported 154 
1495 cross-links that were used in a hybrid modelling pipeline to predict the HSA 155 
domains that broadly agreed with the known crystal structure7. 156 
 HD-CLMS has now been incorporated into the Critical Assessment of 157 
protein Structure Prediction (CASP), a community effort to test the success of 158 
algorithms for predicting structures of proteins for which the structure is known 159 
but is yet to be publicly released. HD-CLMS debuted at CASP11 where the 160 
inclusion of HD-CLMS restraints produced a modest improvement over other 161 
molecular modelling approaches but most importantly, it provided a foundation 162 
on which to design further integration of this data40,41.  163 
Additional complementary cross-links such as those with a shorter spacer 164 
length to give tighter distance restraints, or cross-links in the core of the protein 165 
by photoactivatable amino acids will provide more restraints for proteins that are 166 
difficult to model. HD-CLMS may become an invaluable tool for solving novel 167 
structures that have to date evaded standard structural biology techniques. 168 
Quantitative CLMS for comparative studies 169 
Generally, CLMS data has been interpreted under the assumption that the 170 
investigated protein or protein complexes are static entities. However, a purified 171 
protein can be an ensemble of many different states. Thus, CLMS studies often 172 
produce high-confidence cross-links that cannot be explained by the available 173 
crystal structures used to benchmark them. Some of these discrepancies may 174 
represent conformations that are present in solution but are not available in the 175 
PDB42. Since cross-linking data can represent a mixture of all of the 176 
conformations occuring in the system, a careful analysis of long-distance cross-177 
links can be used to separate these alternative conformations. This approach has 178 
led to key insights into the GRK5 interaction with the b2-adrenergic receptor43. 179 
 The analysis of conformational changes by cross-linking is eased by 180 
designing comparative analyses44,45 such as using isotope-labelling techniques, 181 
which allow direct comparison of the abundances of specific cross-links between 182 
different protein states (Fig. 2c). Early applications of this method were to 183 
investigate the conformational changes that take place after spontaneous 184 
hydrolysis of a thioester bond in the complement protein C346 and the impact of 185 
phosphorylation on the conformation of an F-type ATPase, by comparing cross-186 
links derived from complexes treated with either BS3-d0 or BS3-d447. The 187 
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relative abundances of the cross-links were compared manually. Since then, 188 
efforts have been made to automate this approach with XiQ45, xTract48 and 189 
incorporation into MaxQuant49. Other applications of this technology have shown 190 
large conformational rearrangements that occur in the proteasome during particle 191 
assembly50, the regulation of enzymes48,51,52 and the regulation of protein 192 
interactions53,54. 193 
QCLMS has shown the most success in cases where conformational 194 
equilibria can be strongly shifted by, for example, effector binding or post-195 
translational modifications. However, even subtle structural changes that result in 196 
altered residue proximities, solvent accessibility or steric hindrances have also 197 
been observed to affect the formation and yield of cross-links55. Great care 198 
should be taken in interpreting cross-link changes if factors affecting cross-link 199 
reactivity are changed, for example differences in pH, or factors affecting 200 
digestion such as differential post-translational modification. 201 
CLMS applied to proteome-wide scales 202 
CLMS offers the possibility to generate distance restraints across the entire 203 
proteome that reveal medium resolution structural information of proteins and 204 
their interactions (Fig. 2d). This is extremely ambitious due to the complexity of 205 
the starting material. Complexity here refers to the total proteins in the sample 206 
and all possible combinations of their resulting peptides that need to be 207 
considered during data analysis.  208 
Cellular PPIs range from stable 'core' complexes to very transient 209 
interactions. Large-scale proteomics studies that have provided the most 210 
comprehensive PPI maps by affinity-purification/mass spectrometry56,57 or co-211 
fractionation58,59 do not reveal the physical arrangement of proteins within the 212 
identified complexes. CLMS can add this missing topological information to the 213 
PPI maps and also capture interactions that may be lost during purification. The 214 
number of different proteins, the range of abundances and the post-translational 215 
modifications in the cell makes the detection of cross-links for all but the most 216 
abundant proteins difficult. Nevertheless, rapid technological advancements in 217 
CLMS are now allowing production of PPI networks on starting material that only 218 
a few years ago would have been impossibly complex.  219 
 In general, there are three different approaches to generating starting 220 
material for CLMS-based PPI maps; targeted pull-downs, cell lysates and in situ 221 
cross-linking.  222 
Pull-down studies that enrich the native complex being investigated 223 
combined with on-bead cross-linking can provide topological information that can 224 
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be used to separate direct binders from background60–62. In the case of protein 225 
phosphatase 2A (PP2A), pull-downs and on-bead cross-linking were used to 226 
disentangle a complicated interaction network that consists of many different 227 
isoforms14. Whereas particularly transient interactions are lost during these pull-228 
down protocols, there have also been promising studies using in situ stabilisation 229 
of the tagged protein complexes by cross-linking in their native environment prior 230 
to the pull-down. These studies have utilised cross-linkers that can penetrate cell 231 
membranes and cross-link protein complexes in cells or in organelles. The 232 
tagged proteins can be pulled-down along with their interaction network under 233 
denaturing conditions, and this approach has been used most notably in the 234 
proteasome interactome63.  235 
 CLMS studies applied to the whole soluble proteome in cell lysates have 236 
reported several hundreds of PPIs in several species, including human cell 237 
lines6,64–66. The data generated so far has been sparse and the majority of the 238 
cross-links are within abundant and well-characterised complexes such as the 239 
nucleosome, ribosome and proteasome. While a single confident inter-protein 240 
cross-link is enough to confirm an interaction, it is preferable to get a density of 241 
cross-link distance restraints that would provide topological information. One 242 
possibility to navigate around this complexity is to cross-link cell lysates simplified 243 
by biochemical fractionation67.  244 
Several attempts have been made to produce cross-link-based interaction 245 
maps in situ in cells or organelles without genetic tagging or pull-downs in order 246 
to preserve the important contribution of molecular crowding to in vivo 247 
interactions, and to maintain the most physiologically relevant conditions. These 248 
approaches produce the most complex starting material of all and although the 249 
cross-linkers used are often chemically enrichable, here too only moderate 250 
numbers of cross-links are identified4,68–71. Excitingly, even with current 251 
superficial insights, cross-linking intact cells has revealed interesting biology 252 
including the interaction dynamics of HSP9072, interactions between bacterial 253 
virulence factors and host proteins73, and it has suggested supercomplexes in 254 
the mitochondrial oxidative phosphorylation system4,71. Cross-links can be used 255 
to check the proposed folds of homology models of protein structures from 256 
species that had not been previously structurally investigated67. 257 
Many novel interactions and previously unknown quaternary structures 258 
have been identified in these in situ studies but often with insufficient numbers of 259 
cross-links to enable modelling of the interacting surfaces or docking. Using the 260 
NHS-ester cross-linker DSS, it is possible to identify in the order of 50-100 cross-261 
links on a typical purified protein, so for a human proteome cross-linking 262 
experiment, a crude conservative estimate is that >200,000 cross-links are there 263 
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to be identified within and between the 4000 most abundant proteins. This 264 
represents a significant analytical challenge and demonstrates that 265 
improvements in the enrichment and analysis of cross-linked peptides are 266 
required.  267 
 268 
3. CLMS workflows 269 
The development of standardised reagents and workflows have hugely increased 270 
the ease-of-use of CLMS, though the abundance of available workflows may 271 
cause confusion to newcomers. Below, we discuss the major integrated CLMS 272 
workflows that are streamlined pipelines built around specific cross-linker 273 
chemistries and search software. There are now numerous different software 274 
solutions available for identifying cross-linked peptides74. Regardless of the 275 
search software used, the standard method to gauge confidence is FDR 276 
estimation by a target-decoy approach30,75,76. Reporting standards (Box 1) and 277 
data visualisation software (Box 2 and Fig. 3) are easing interpretation and 278 
transfer of results necessary for the democratisation of this technique.  279 
Importantly, the chemistry of the cross-linker spacer (the part remaining 280 
after a cross-link is formed) can be modified to aid data analysis and give 281 
confidence to the identified cross-links. Therefore, the most suitable cross-linker 282 
in combination with the analysis pipeline should be carefully considered before 283 
embarking on a study.  284 
Universal approach  285 
This is the broadest approach that requires no modification to the cross-linker 286 
spacer to aid downstream analysis. This is widely used in combination with 287 
standard commercial cross-linkers and is particularly useful for cross-linkers that 288 
are currently incompatible with modification of their spacer region, such as photo 289 
amino acids2,77. Isotope-labelling is not required for identification and can 290 
consequently be used for quantitative or comparative studies (Fig. 4a).  291 
This strategy takes advantage of the accuracy with which modern mass 292 
spectrometers can record fragmentation spectra. The high mass accuracy limits 293 
the chance of false positives by randomly matching signals to the database of 294 
potential cross-linked peptides. Many software suites, including StavroX78, Xlink-295 
Identifier79 and Xcomb80 generate a database of potential cross-linked pairwise 296 
peptide combinations, but as the number of proteins increases, they can require 297 
impractical amounts of computational time. Other approaches use an open 298 
modification search strategy where each cross-linked spectrum is searched as 299 
two peptides, each with a modification of an unknown mass at an unknown 300 
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residue/lysine81. Commonly used search strategies also combine the modification 301 
search with experimental heuristics that enrich for potential cross-linked peptides 302 
computationally to save search time before scoring the spectra, including Xi82, 303 
Plink65, XLSearch83, Protein Prospector84, ECL285 and Kojak86.  304 
 Xi, a search software of our design, first linearises spectra in silico82 and 305 
then performs a simple linear search on that spectra, which outputs a list of 306 
candidates for one of the linked peptides. The linearisation step uses an 307 
empirical understanding of the fragmentation spectra of cross-linked peptides, 308 
revealing cross-linked fragments due to their charge and fractional mass. Some 309 
peptides do not fragment well so we do not necessarily expect to identify both 310 
cross-linked peptides in this first step. For each of the candidates, the mass of 311 
this first peptide and the mass of the cross-linker are known. Consequently, a 312 
mass of the second peptide can be calculated (precursor mass – (cross-linker + 313 
peptide 1)). Every peptide that fits this mass is considered as a candidate peptide 314 
and all predicted pairs are used to score the whole spectrum. Xi identifies up to 315 
~20% more links compared to algorithms that only consider Lys-Lys linkages by 316 
also searching side reactions of the amine-reactive cross-linker with serine, 317 
threonine and tyrosine residues87. Xi also permits the search for products of 318 
photo-cross-linking to obtain high-density CLMS data7. A false discovery rate 319 
(FDR) for this data can be calculated using a target-decoy approach with our 320 
software xiFDR75 that has an integrated option to further increase identifications 321 
through noise reduction.  322 
Labelled cross-linker approach 323 
This approach is designed to indicate in the first mass spectrometry stage (MS1) 324 
which peptides contain a cross-linker, whether those are cross-linked peptides or 325 
simply cross-linker modified peptides (i.e. mono-links), and to reveal cross-linked 326 
fragments (Fig. 4b). This helps to identify cross-links, which is especially 327 
beneficial for confident cross-link identification in cases where high-accuracy 328 
mass spectrometers are not available. It also simplifies the data analysis 329 
workflow. Several labelling strategies exist88–90. The most common is to use a 1:1 330 
mixture of heavy and light isotope-labelled cross-linkers during the reaction. This 331 
produces a characteristic doublet in MS1 spectra that is recognised by search 332 
software. Several search software take advantage of this approach including: 333 
Hekate91, StavroX78 and the popular xQuest92. 334 
For example, xQuest identifies the linked peptides using the fragmentation 335 
spectra (MS2) of both the light- and heavy-labelled MS1 precursors. Linear 336 
peptide fragments, which do not contain the labelled cross-linker are common 337 
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peaks in both fragmentation spectra and can be used to map the two cross-338 
linked peptides93 (Fig. 4b). This reduces the potential search space by generating 339 
lists of candidate peptides that can then be scored against the full MS2 spectra. 340 
xProphet, a software package that is paired with xQuest, then calculates FDRs 341 
using a target-decoy approach76.  342 
 However ,this elegant approach has disadvantages. Peptides modified 343 
with the isotopically heavy and normal cross-linker can differ in retention time on 344 
the reverse-phase liquid chromatography in line with the mass spectrometer, 345 
which can make it difficult to identify the pairs. Requiring both the heavy and light 346 
precursors to be picked for fragmentation can cause issues in complex samples. 347 
Labelling with a 1:1 ratio of light/heavy cross-linker causes the intensity of the 348 
cross-linked peptides to be halved relative to the unlabelled linear peptides in the 349 
sample. This decreases the likelihood that their precursors are selected for 350 
fragmentation Labelling also increases the complexity of the MS1 spectral space, 351 
which can negatively affect identification rates. Moreover, use of labelled cross-352 
linkers to identify linked peptides prevents their use of this for QCLMS (see 353 
‘Quantitative CLMS for comparative studies’).  354 
MS2-cleavable cross-linker approach 355 
Cross-linked peptides are large and branched, which gives rise to complicated 356 
fragmentation spectra and uneven fragmentation. The large number of potential 357 
peptide combinations in conjunction with the often poor fragmentation of one of 358 
the cross-linked peptides can make it difficult to confidently identify the two 359 
peptides. Separating the two peptides in the mass spectrometer simplifies the 360 
analysis to identifying two individual linear peptides (Fig. 4c). 361 
Consequently, considerable effort has been expended on creating cross-362 
linkers that are cleavable in the mass spectrometer so that spectra simply 363 
correspond to two modified peptides94–105 . 364 
MS2-cleavable cross-linker approaches tend to cleave asymmetrically 365 
during mass spectrometric fragmentation, which provides distinctive cross-link 366 
specific product ions that report the presence of cross-linked peptides. DSSO 367 
(see Table 1), for example, cleaves asymmetrically leaving a distinctive group of 368 
4 peaks after CID (collision-induced dissociation) fragmentation: peptide A with 369 
the longer arm of the cleaved DSSO, peptide B with the shorter arm and vice 370 
versa94 (Fig. 4c). These can be selected for further fragmentation (MS3), which 371 
simplifies the spectra to that of a simple modified peptide with a measured parent 372 
m/z and therefore aids identification. The use of MS3 requires an instrument that 373 
is capable of doing MS3 - and this technique takes longer duty cycles than the 374 
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MS2-only approaches discussed above. Acquisition approaches for these cross-375 
linkers have subsequently been designed by several laboratories along with their 376 
respective search software such as ICC-CLASS106, MeroX107, X-links/Blinks108,109 377 
and XlinkX2.06,66.  378 
In the XlinkX pipeline, a mixed approach is recommended by performing 379 
sequential CID and ETD (electron-transfer dissociation) fragmentation on each 380 
precursor. Fragment ions displaying the characteristic doublets of DSSO are 381 
selected for further MS3 analysis66. The information from all three of these 382 
fragmentation approaches is then combined for identification. This data 383 
integration circumvents a large drawback with this approach whereby the MS2-384 
cleavage of the cross-linker is often inefficient and therefore doublet peaks are 385 
not always obvious for selection for MS3. 386 
 387 
4. Future prospects 388 
The field of CLMS is providing powerful tools to molecular biologists to aid 389 
structural biology and interactome research. CLMS has matured into a core 390 
technique for in vitro structural studies that is capable of delivering medium 391 
resolution information to complement classical atomic resolution structural 392 
biology techniques and computational modelling. CLMS results from a purified 393 
protein complex can be generated and analysed in under a week by most 394 
proteomics core facilities. The addition of QCLMS, which may soon become 395 
routine, means that structural differences caused by conformational changes or 396 
mutations can be assessed in solution. HD-CLMS has demonstrated potential for 397 
aiding the characterisation of tertiary protein structure in combination with 398 
computational modelling.  399 
 In situ studies of PPIs and protein structures is the next phase of the 400 
CLMS revolution. As work continues towards acquiring data of greater depth, 401 
CLMS may eventually become a widely-used quantitative in cell structural 402 
technique to monitor interactions and conformational changes simultaneously. 403 
Several hundreds to thousands of cross-linked residue pairs can be identified 404 
from purified protein complexes so the few thousands of cross-linked peptides 405 
that have so far been detected in ‘proteome-wide’ studies are only the tip of the 406 
iceberg. Improved cross-linked peptide enrichment, cross-linker chemistries, and 407 
further progress in data acquisition and analysis will allow us to map many tens 408 
of thousands of cross-links within the cell and elucidate protein topologies in situ 409 
at a true proteome-wide scale. One envisions a time in the near future when 410 
CLMS will be used to routinely map entire protein interactomes and their 411 
dynamics during biological processes such as cellular differentiation, 412 
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development and the transition from health to disease.  413 
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Cross-linker Spacer length Residue reactivity 
BS3/DSS 11.4 Å K/S/T/Y/N-terminus - K/S/T/Y 
DSSO 10.3 Å K/S/T/Y/N-terminus - K/S/T/Y 
EDC 0 Å D/E - K/S/T/Y 
DMTMM + spacer 
dihydrazine 
 
Depends on 
spacer 
D/E - D/E 
SDA 3.4 Å K/S/T/Y/N-terminus - Any 
Table 1| A selection of commonly used soluble cross-linkers and their 427 
reactivities. Cross-linkers comprise two elements: reactive end-groups and a 428 
spacer. The reactive groups dictate which residues are targeted and thereby the 429 
amount of spatial information that can be obtained. Cross-linkers that target 430 
specific reactive groups generate fewer potential combinations of cross-linked 431 
residues, which limits the amount of structural information but also eases the 432 
data analysis. The spacer region of the cross-linker is what remains when two 433 
residues are cross-linked and largely determines the workflow to be used 434 
including the MS acquisition method and data analysis. The spacer also 435 
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influences the spatial resolution and data density. A longer spacer will allow more 436 
residue combinations to fall within a cross-linker’s range, which may be beneficial 437 
if the main goal is to identify proteins (not necessarily the residues) that are in 438 
close proximity. However, a longer spacer also reduces the information value of 439 
a cross-link as a cross-link only produces an upper bound distance restraint. 440 
 441 
  442 
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Box 1: Reporting standards 443 
The field has not yet settled on minimal reporting standards. This has 444 
disadvantages for assessing publications and reusing data for modelling. The 445 
proteomics standards initiative (HUPO-PSI) has developed an XML-based 446 
reporting standard for proteomics data, mzIdentML 447 
(http://www.psidev.info/mzidentml), which from version 1.2 includes CLMS110. 448 
Published mass spectrometric raw data should be deposited in 449 
ProteomeXchange. When reporting results, there is a need for disambiguation 450 
with regards to the term ‘cross-link’, which is often used without clear distinction 451 
for peptide spectral matches (PSMs), peptide pairs and residue pairs. This is 452 
confusing when trying to assess data quantity, as PSMs and peptide pairs 453 
contain redundant information, and can lead to serious flaws in data reliability75. 454 
As a minimum, authors must define the term and use it consistently. 455 
 456 
Box 2: Data visualisation and interpretation 457 
Commonly, laboratories interested in applying CLMS to their structural problem 458 
will collaborate with laboratories that specialise in CLMS or proteomics core 459 
facilities to generate data. To facilitate the accessibility and interpretation of 460 
CLMS results for experts and non-experts, software has been developed by 461 
several laboratories for visualising the identified cross-links and the mass spectra 462 
that led to their identification91,111–117. Cross-linking studies provide many levels of 463 
information; residue-residue links, 3D structural information (when integrated with 464 
atomic level information) and protein-protein interactions, which has required 465 
bespoke visualisations (Fig. 3).  466 
 467 
  468 
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 469 
 470 
Fig. 1| General CLMS workflow. a, Cross-linkers can contain various 471 
chemistries and lengths. Depending on the experimental workflow used (see 472 
CLMS data analysis and integrated workflows), the cross-linker spacer may need 473 
to be cleavable, labelled or have enrichable moieties. Reactive groups are also 474 
variable (Table 1). b, Concentrations and reaction times need to be empirically 475 
checked for each application to achieve optimal amounts of cross-linking. c, 476 
Proteins can be digested in solution or in gel to produce a mixture of cross-linked 477 
and linear peptides. d, After digestion cross-linked peptides are often enriched 478 
due to the large abundance of linear peptides for all applications more complex 479 
than a single protein. This can be achieved by chromatographic methods such as 480 
size exclusion chromatography or strong cation exchange chromatography. e, 481 
MS/MS pipelines have been designed to increase the likelihood of selecting 482 
cross-linked peptide precursors for fragmentation. f, Various search software 483 
solutions are described in the main text that can identify the two linked peptides 484 
from the spectra. 485 
 486 
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 487 
Fig. 2| CLMS applications. a, Distance restraints from CLMS allows docking of 488 
subunits of protein complexes. Together with other structural techniques such as 489 
cryo-EM can be used to provide medium to high resolution structural information 490 
for previously intractable complexes. b, High-density cross-linking using photo-491 
activatable cross-linkers, while limited by sample complexity provides data 492 
density that can be used to guide algorithms that fold the tertiary structure of 493 
proteins using de novo or database aided approaches. c, QCLMS can describe 494 
structural differences between two protein/protein complex conformations by 495 
using isotope labelling to compare the abundances of cross-links detected in 496 
different samples. d, The complexity of samples analysed by CLMS has 497 
increased in recent years to include cell lysates and in situ analyses of organelles 498 
and whole cells. It is also possible to target specific interaction networks by 499 
cross-linking the cells and then pull-down a specific protein and its interactors.  500 
 17 
 
 501 
Fig. 3| Visualisation solutions for CLMS data. a, Spectra identified as cross-502 
linked peptides can be manually assessed. To aid this, spectral viewer 503 
XiSPEC118 highlights fragment peaks have been used to identify the linked 504 
peptides and their fragmentation coverage. b, Cross-linked proteins can be 505 
visualised using node and edge graphs to display interconnectivity of proteins. 506 
Intralinks and interlinks are visualised at residue and domain resolution by 507 
representing the proteins as bars or concatenated into circle plots, as used in 508 
XiNet111 and XVis112. Cross-linked edges can also be colored to aid interpretation 509 
of qCLMS data. c, Mapping of cross-links on known 3D structures or homology 510 
models can score and validate cross-links and show those that violate the 511 
distance restraints, as implemented in xiNET111, Xlink Analyzer113 , XLink-DB114, 512 
Xwalk115, CLMSVault116, ProXL117 and Hekate91. This same information can be 513 
visualised as a distogram - a histogram that shows the distribution of cross-link 514 
distances in the data111. Normally a distance restraint is considered satisfied if 515 
the euclidean distance between Cα’s is less than the cross-linker spacer, plus the 516 
side chains, plus an empirically derived short distance accounting for flexibility in 517 
the peptide backbone 518 
 519 
 520 
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 521 
Fig. 4| CLMS data acquisition and analysis workflows. a, The ‘universal 522 
approach’ uses cross-linkers with simple spacers. The fragmentation spectra are 523 
a mixture of fragments from both peptides and must be resolved during database 524 
search. b, The sample is cross-linked with a mixture of cross-linker and its heavy 525 
isotope labeled counterpart. Here usually all MS1 precursors are fragmented and 526 
during database searching the MS1 doublets (peaks separated by the mass 527 
difference between the cross-linkers) are used to indicate spectra that contain 528 
cross-linker. When the MS2 spectra from heavy and light labeled peptides are 529 
compared, peaks with a shifted mass (here indicated with stars) indicate 530 
fragments that contain the cross-linker and can therefore simplify data analysis. 531 
c, The ‘MS cleavable cross-linker approach’ can be done in one of two ways. The 532 
cross-linker is cleavable in the MS2, often asymmetrically, so it produces 533 
fragments that indicate the separate masses of the two cross-linked peptides. 534 
These MS2 spectra can be used alone for the database search or, more 535 
commonly, the characteristic doublet ions from the asymmetrically cleaved cross-536 
linker are selected for MS3 fragmentation of each peptide separately during 537 
acquisition. These MS3 spectra are then used for database searching along with 538 
the deduced masses of the parent peptides. 539 
 540 
 541 
 542 
 543 
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